Indivior Pharmaceuticals Inc
INDV
Peringkat dalam Saham
#4003
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Harga Saham
$32.56
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$4.06B
Perubahan (1 hari)
-3.15%
Perubahan (1 tahun)
33.01%
Negara
US
Perdagangan Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
EPS untuk Indivior Pharmaceuticals Inc (INDV)
EPS per June 2026 TTM: $2.84
Menurut laporan keuangan terbaru dan harga saham Indivior Pharmaceuticals Inc, EPS perusahaan saat ini (TTM) adalah $2.84. Pada akhir 2023, perusahaan memiliki EPS sebesar $0.01 peningkatan dibandingkan EPS tahun 2022 sebesar $-0.37.
Riwayat EPS untuk Indivior Pharmaceuticals Inc dari 2016 hingga 2026
EPS di akhir setiap tahun
| Tahun | EPS | Mengubah |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS untuk perusahaan sejenis atau pesaing
| Perusahaan | EPS | Perbedaan EPS | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
